Gossamer Bio, Inc.
GOSS
$2.41
-$0.055-2.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -138.74M | -51.24M | -56.53M | -71.65M | -80.85M |
| Total Depreciation and Amortization | 2.73M | 3.51M | 4.15M | 4.08M | 4.07M |
| Total Amortization of Deferred Charges | 958.00K | 1.03M | 1.09M | 1.16M | 1.25M |
| Total Other Non-Cash Items | 3.66M | 5.02M | 8.36M | 19.03M | 21.56M |
| Change in Net Operating Assets | -22.90M | 50.79M | 39.46M | 45.97M | 50.10M |
| Cash from Operations | -154.30M | 9.11M | -3.47M | -1.41M | -3.87M |
| Capital Expenditure | -79.00K | -26.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.73M | -10.56M | 29.02M | -38.56M | -130.07M |
| Cash from Investing | 92.65M | -10.59M | 29.02M | -38.56M | -130.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -9.68M | -12.58M | -15.48M | -18.39M |
| Issuance of Common Stock | 879.00K | 785.00K | 629.00K | 629.00K | 201.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 464.00K | 464.00K | 464.00K | 464.00K |
| Cash from Financing | 879.00K | -8.43M | -11.49M | -14.39M | 183.83M |
| Foreign Exchange rate Adjustments | 202.00K | 65.00K | -102.00K | 216.00K | -13.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.57M | -9.84M | 13.97M | -54.15M | 49.87M |